BTMD | tickerfilter.com

Fundamental analysis

89%

Profitability 100%

Dept financing 50%

Liquidity 41%

Performance 100%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.92%

1 Month

22.91%

3 Months

3.29%

6 Months

-15.38%

1 Year

-43.73%

2 Year

-63.39%

Key data

Stock price

$2.20

P/E Ratio

N/A

DAY RANGE

$2.10 - $2.25

EPS

$1.10

52 WEEK RANGE

$1.27 - $4.75

52 WEEK CHANGE

-$44.16

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

39.551 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-06-2025

BETA

1.02

PUBLIC FLOAT

AVERAGE 10 VOLUME

$226,574

AVERAGE 30 VOLUME

$206,222

Company detail

CEO: Terry S. Weber
Region: US
Website: biote.com
Employees: 0
IPO year: 2021

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.

BTMD - biote Corp.